Funding
This study was funded by Healios K.K., licensee (in Japan) of invimestrocel. Healios K.K. was involved in the study design, data collection, data analysis, and preparation of the manuscript. Medical writing assistance was provided by Prudence Stanford, PhD, CMPP, and Rebecca Lew, PhD, CMPP, of ProScribe—Envision Pharma Group, and was funded by Healios K.K. ProScribe’s services complied with international guidelines for Good Publication Practice.